COVID-19 ACTIV-4 ACUTE: A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 (ACTIV4A)

Request Access

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

E. Goligher, C. Bradbury, B. McVerry, et al.. (2021). The New England Journal of Medicine. Cited 692 times. https://doi.org/10.1056/NEJMoa2103417

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

P. Lawler, E. Goligher, J. Berger, et al.. (2021). The New England Journal of Medicine. Cited 679 times. https://doi.org/10.1056/NEJMoa2105911

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.

J. Berger, L. Kornblith, M. Gong, et al.. (2022). JAMA. Cited 96 times. https://doi.org/10.1001/jama.2021.23605
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747